27 February 2018Trademarks
EMA: Playing the percentages
In Europe, around 50% of pharmaceutical brand names are rejected by the European Medicines Agency (EMA), according to anecdotal evidence. Yes, you read that right—one in two names is dismissed, and yes, it’s the EMA that has the ultimate say.
